A detailed history of Patten & Patten Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Patten & Patten Inc holds 185,936 shares of ABBV stock, worth $33.5 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares
185,936
Previous 188,212 1.21%
Holding current value
$33.5 Million
Previous $32.3 Million 13.74%
% of portfolio
2.57%
Previous 2.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $372,899 - $453,675
-2,276 Reduced 1.21%
185,936 $36.7 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $599,501 - $700,083
-3,873 Reduced 2.02%
188,212 $32.3 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $30.7 Million - $35 Million
192,085 New
192,085 $35 Million
Q4 2023

Jan 23, 2024

SELL
$137.6 - $154.97 $80,496 - $90,657
-585 Reduced 0.3%
194,533 $30.1 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $90,974 - $105,316
681 Added 0.35%
195,118 $29.1 Million
Q2 2023

Jul 14, 2023

BUY
$132.51 - $164.9 $1.06 Million - $1.32 Million
7,978 Added 4.28%
194,437 $26.2 Million
Q1 2023

Apr 25, 2023

SELL
$144.61 - $166.54 $329,276 - $379,211
-2,277 Reduced 1.21%
186,459 $29.7 Million
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $677,719 - $812,763
-4,900 Reduced 2.53%
188,736 $30.5 Million
Q3 2022

Oct 19, 2022

SELL
$134.21 - $153.93 $290,027 - $332,642
-2,161 Reduced 1.1%
193,636 $26 Million
Q2 2022

Aug 02, 2022

SELL
$137.62 - $174.96 $782,232 - $994,472
-5,684 Reduced 2.82%
195,797 $30 Million
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $720,478 - $893,911
-5,459 Reduced 2.64%
201,481 $32.7 Million
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $234,089 - $296,191
-2,179 Reduced 1.04%
206,940 $28 Million
Q3 2021

Oct 22, 2021

BUY
$106.4 - $120.78 $37,984 - $43,118
357 Added 0.17%
209,119 $22.6 Million
Q2 2021

Jul 13, 2021

BUY
$105.21 - $117.21 $581,495 - $647,819
5,527 Added 2.72%
208,762 $23.5 Million
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $299,125 - $329,300
2,924 Added 1.46%
203,235 $22 Million
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $447,524 - $604,205
5,560 Added 2.85%
200,311 $21.5 Million
Q3 2020

Oct 08, 2020

BUY
$85.91 - $100.83 $772,674 - $906,865
8,994 Added 4.84%
194,751 $17.1 Million
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $105,946 - $141,771
1,444 Added 0.78%
185,757 $18.2 Million
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $85,914 - $130,256
1,332 Added 0.73%
184,313 $14 Million
Q4 2019

Jan 13, 2020

BUY
$72.13 - $90.25 $1.17 Million - $1.46 Million
16,189 Added 9.71%
182,981 $16.2 Million
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $24,247 - $29,152
385 Added 0.23%
166,792 $12.6 Million
Q2 2019

Jul 11, 2019

SELL
$65.7 - $83.98 $600,038 - $766,989
-9,133 Reduced 5.2%
166,407 $12.1 Million
Q1 2019

Apr 23, 2019

SELL
$77.14 - $90.79 $131,909 - $155,250
-1,710 Reduced 0.96%
175,540 $14.1 Million
Q4 2018

Jan 17, 2019

SELL
$77.85 - $96.01 $779,434 - $961,252
-10,012 Reduced 5.35%
177,250 $16.3 Million
Q3 2018

Oct 17, 2018

BUY
$88.91 - $98.84 $246,280 - $273,786
2,770 Added 1.5%
187,262 $17.7 Million
Q2 2018

Jul 18, 2018

BUY
$89.78 - $106.23 $133,233 - $157,645
1,484 Added 0.81%
184,492 $17.1 Million
Q1 2018

Apr 20, 2018

SELL
$92.01 - $123.21 $91,457 - $122,470
-994 Reduced 0.54%
183,008 $17.3 Million
Q4 2017

Jan 22, 2018

SELL
$89.56 - $98.21 $374,181 - $410,321
-4,178 Reduced 2.22%
184,002 $17.8 Million
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $13.1 Million - $16.8 Million
188,180
188,180 $16.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Patten & Patten Inc Portfolio

Follow Patten & Patten Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.